Palantir shares are under pressure today, down about 4.6% to $130.97, as traders fade the recent momentum that benefited AI-and-defense adjacent names during heightened geopolitical risk. The move looks less like a single-company shock and more like a rapid repricing of sentiment in a stock that has been trading with a sizable “expectations premium.”

The most current narrative behind today’s decline is an unwind in perceived geopolitical upside—an easing signal in the Iran backdrop is prompting investors to take profits in names viewed as beneficiaries of elevated conflict-driven government tech/defense spending. At the same time, the selloff is being reinforced by recurring concerns that Palantir’s valuation leaves little room for disappointment, making the stock especially sensitive to any shift in risk appetite.

Another factor weighing on sentiment is renewed discussion of UK scrutiny around AI use in government and healthcare contexts. Even without a new enforcement event, the re-emergence of regulatory-overhang headlines can pressure a high-multiple stock by raising the perceived risk of slower adoption, added compliance friction, or reputational constraints in public-sector deployments.

Near-term, traders will be watching for follow-through in broader tech risk sentiment, any fresh contract announcements, and any incremental regulatory updates that could either validate or relieve today’s concerns. With the stock’s multiple already embedding aggressive growth expectations, the next company update that clearly confirms demand durability—or hints at margin/growth normalization—could drive an outsized move in either direction.